Stock Scorecard
Stock Summary for Aurinia Pharmaceuticals Inc (AUPH) - $15.99 as of 7/2/2026 7:18:44 AM EST
Total Score
18 out of 30
Safety Score
53 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for AUPH
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AUPH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AUPH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AUPH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AUPH (53 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 8 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AUPH
Financial Details for AUPH
Company Overview |
|
|---|---|
| Ticker | AUPH |
| Company Name | Aurinia Pharmaceuticals Inc |
| Country | USA |
| Description | Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 7/30/2026 |
Stock Price History |
|
| Last Day Price | 15.99 |
| Price 4 Years Ago | 4.32 |
| Last Day Price Updated | 7/2/2026 7:18:44 AM EST |
| Last Day Volume | 2,033,221 |
| Average Daily Volume | 1,671,419 |
| 52-Week High | 19.25 |
| 52-Week Low | 7.36 |
| Last Price to 52 Week Low | 117.26% |
Valuation Measures |
|
| Trailing PE | 7.31 |
| Industry PE | 26.12 |
| Sector PE | 45.28 |
| 5-Year Average PE | 43.05 |
| Free Cash Flow Ratio | 49.97 |
| Industry Free Cash Flow Ratio | 24.75 |
| Sector Free Cash Flow Ratio | 30.81 |
| Current Ratio Most Recent Quarter | 5.55 |
| Total Cash Per Share | 0.32 |
| Book Value Per Share Most Recent Quarter | 4.34 |
| Price to Book Ratio | 3.58 |
| Industry Price to Book Ratio | 5.88 |
| Sector Price to Book Ratio | 17.41 |
| Price to Sales Ratio Twelve Trailing Months | 6.81 |
| Industry Price to Sales Ratio Twelve Trailing Months | 10.22 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.87 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 128,602,000 |
| Market Capitalization | 2,056,345,980 |
| Institutional Ownership | 60.26% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 56.30% |
| Annual Earnings Growth | 4,893.08% |
| Reported EPS 12 Trailing Months | 2.16 |
| Reported EPS Past Year | 0.25 |
| Reported EPS Prior Year | 0.81 |
| Net Income Twelve Trailing Months | 298,213,000 |
| Net Income Past Year | 287,202,000 |
| Net Income Prior Year | 5,752,000 |
| Quarterly Revenue Growth YOY | 24.40% |
| 5-Year Revenue Growth | 41.38% |
| Operating Margin Twelve Trailing Months | 53.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 41,008,000 |
| Total Cash Past Year | 80,213,000 |
| Total Cash Prior Year | 83,433,000 |
| Net Cash Position Most Recent Quarter | 41,008,000 |
| Net Cash Position Past Year | 80,213,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 581,331,000 |
| Total Stockholder Equity Prior Year | 377,478,000 |
| Total Stockholder Equity Most Recent Quarter | 567,626,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 165,549,340 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.29 |
| Free Cash Flow Past Year | 135,406,000 |
| Free Cash Flow Prior Year | 44,107,000 |
Options |
|
| Put/Call Ratio | 0.10 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.36 |
| MACD Signal | 0.38 |
| 20-Day Bollinger Lower Band | 13.38 |
| 20-Day Bollinger Middle Band | 15.02 |
| 20-Day Bollinger Upper Band | 16.66 |
| Beta | 1.42 |
| RSI | 54.90 |
| 50-Day SMA | 12.75 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 7/2/2026 6:36:16 PM EST |